Literature DB >> 8966836

Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat.

L Vinter-Jensen1, M Smerup, P E Jørgensen, C O Juhl, T Orntoft, S S Poulsen, E Nexø.   

Abstract

Twenty-four male Wistar rats, 8 weeks old, were allocated into three groups and treated with human recombinant epidermal growth factor (EGF) administered subcutaneously in doses of 0, 30, and 150 micrograms/kg per day for 4 weeks. Blood sampling was done every 2nd week and urine sampling was done for 2 consecutive days every week. The most striking finding was that the ureters were dose dependently enlarged, due to growth of all layers of the ureteric wall. The urothelium of the bladder showed considerable hyperplasticity with a widening of the basal proliferative compartment and a normal differentiation pattern as observed by the expression of carbohydrate epitopes, characterized with lectinohistochemistry. Blood examination revealed a decrease in blood haemoglobin concentration and a slight increase in serum creatinine concentration in the high-dose group. There were no effects of EGF on the urinary excretion of electrolytes, proteins, and endogenous EGF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8966836     DOI: 10.1007/bf00296727

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  29 in total

1.  Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule.

Authors:  R C Harris; T O Daniel
Journal:  J Cell Physiol       Date:  1989-05       Impact factor: 6.384

2.  Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor.

Authors:  S Noguchi; Y Yura; E R Sherwood; H Kakinuma; N Kashihara; R Oyasu
Journal:  Lab Invest       Date:  1990-05       Impact factor: 5.662

3.  Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity.

Authors:  T M Coimbra; D A Cieslinski; H D Humes
Journal:  Am J Physiol       Date:  1990-09

4.  Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs.

Authors:  C O Juhl; L Vinter-Jensen; O Myhre-Jensen; L S Jensen; E Z Dajani
Journal:  Clin Sci (Lond)       Date:  1995-10       Impact factor: 6.124

5.  Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor.

Authors:  C B Gow; P A Phillips; K D Chandler; G P Moore
Journal:  Am J Physiol       Date:  1993-07

6.  Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.

Authors:  R A Goodlad; T J Wilson; W Lenton; H Gregory; K G McCullagh; N A Wright
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

7.  Evidence for glomerular actions of epidermal growth factor in the rat.

Authors:  R C Harris; R L Hoover; H R Jacobson; K F Badr
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Blood group precursor T-antigen expression in human urinary bladder carcinoma.

Authors:  J S Coon; R S Weinstein; J L Summers
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

9.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

10.  Renal uptake and excretion of epidermal growth factor from plasma in the rat.

Authors:  P E Jørgensen; T N Rasmussen; P Skov Olsen; L Raaberg; S Seier Poulsen; E Nexø
Journal:  Regul Pept       Date:  1990-05-21
View more
  3 in total

1.  Contractile and cytoskeletal proteins in urinary bladder smooth muscle from rats treated with epidermal growth factor.

Authors:  L Vinte-Jensen; B Uvelius; E Nexø; A Arner
Journal:  Urol Res       Date:  1996

2.  Lectins as Biomarkers of IC/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC/BPS Experimental Models.

Authors:  Dominika Peskar; Tadeja Kuret; Jera Jeruc; Andreja Erman
Journal:  Diagnostics (Basel)       Date:  2022-04-25

Review 3.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.